Your pharmacist can discuss what might suit you
"Tirzepatide versus semaglutide once weekly in patients with type 2 diabetes." New England Journal of Medicine , 385(6), 503-515
That is a perfectly reasonable preference, and it is driving one of the most active areas of pharmaceutical development right now
Urgent consultation is warranted for signs of severe dehydration resulting from persistent vomiting or diarrhea, including dizziness, decreased urination, extreme thirst, or confusion
Their effectiveness in lowering body weight versus traditional weight-loss solutions has caught the attention of many consumers
The monitoring parameters of pharmacotherapy with a narrow index also warrant consideration (for example, concurrent warfarin may require closer international normalized ratio monitoring)